Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan
F. Bibeau, E. Crapez, F. Di Fiore, S. Thezenas, J. Sabourin, A. Lamy, T. Frebourg, P. Michel, M. Ychou et F. Boissiere-Michot
Journal of clinical oncology, Vol.26(15_suppl), pp.11004-11004
Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan
Créateurs - sans rôle
F. Bibeau
E. Crapez
F. Di Fiore
S. Thezenas
J. Sabourin
A. Lamy
T. Frebourg
P. Michel
M. Ychou
F. Boissiere-Michot
Détails de publication
Journal of clinical oncology, Vol.26(15_suppl), pp.11004-11004
Identifiants
99140078209311
Unité académique
Institut de Recherche en Cancérologie de Montpellier - IRCM